Adjuvanted trivalent subunit influenza vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adjuvanted trivalent subunit influenza vaccine, covering 2016-07-29 to 2016-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above [Phase 1]